CLARE STONE: Open Payments
NPI 1508576901 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 6 payments from 4 companies in 2025. Trend: 2023 $449 · 2024 $270 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $249 |
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Celgene Corporation | 1 | $26 |
Products named: REZUROCK, NINLARO, REBLOZYL.
Industry payments across NC — which companies pay providers there.
